PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Bemiparin→

Bemiparin PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
9041-08-1
Molecular formula
Not available
Molecular weight
Not available
Drug class
Low-molecular-weight heparin (LMWH)indirect anticoagulant
Mechanism of action
Binds antithrombin and potentiates its inhibition of activated factor Xa, with a smaller effect on thrombin (factor IIa), thereby reducing thrombin generation and fibrin clot formation.
Indications / reported uses
  • Prevention of venous thromboembolic events in patients undergoing selected surgical procedures or immobilisation, according to local product authorisation
  • Treatment of established deep-vein thrombosis in selected jurisdictions and formulations; dose and duration are product-specific

Sources: NLM MeSH — Bemiparin · PubMed — Bemiparin pharmacology and clinical use · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Bemiparin PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Bemiparin Permitted Daily Exposure (PDE) report (the Bemiparin PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Bemiparin Occupational Exposure Limit (OEL) report (the Bemiparin OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.